Published

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: International review of neurobiology
Date: 2025-01-01
Source: PubMed
DOI: 10.1016/bs.irn.2025.03.001
PubMed: 40541316

Authors

Tap S Bostoen T Breeksema J Schoevers R

Watch author

Derived topics and classifications

psilocybin Depression Anxiety End-of-Life Distress Wellbeing Emotional Processing Spirituality Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03

Related papers

Long-term transformative effects and integration challenges of psychedelic experiencesConsciousness Spirituality & Transpersonal Psychology · 2022-09-12 Psilocybin as a healerConsciousness Spirituality & Transpersonal Psychology · 2022-09-12 Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01